Agnes A. Mooslechner

413 total citations
13 papers, 125 citations indexed

About

Agnes A. Mooslechner is a scholar working on Nephrology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agnes A. Mooslechner has authored 13 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 2 papers in Pharmacology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agnes A. Mooslechner's work include Renal Diseases and Glomerulopathies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Agnes A. Mooslechner is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Agnes A. Mooslechner collaborates with scholars based in Austria, Germany and United Kingdom. Agnes A. Mooslechner's co-authors include Alexander R. Rosenkranz, Kathrin Eller, Alexander H. Kirsch, Philipp Eller, Hans‐Dieter Volk, Christian Meisel, Leif G. Hanitsch, Carmen Scheibenbogen, Katharina Artinger and Patricia Grabowski and has published in prestigious journals such as Kidney International, American Journal Of Pathology and European Journal of Immunology.

In The Last Decade

Agnes A. Mooslechner

13 papers receiving 122 citations

Peers

Countries citing papers authored by Agnes A. Mooslechner

Since Specialization

Citations

This map shows the geographic impact of Agnes A. Mooslechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes A. Mooslechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes A. Mooslechner more than expected).

Fields of papers citing papers by Agnes A. Mooslechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes A. Mooslechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes A. Mooslechner. The network helps show where Agnes A. Mooslechner may publish in the future.

Co-authorship network of co-authors of Agnes A. Mooslechner

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes A. Mooslechner. A scholar is included among the top collaborators of Agnes A. Mooslechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes A. Mooslechner. Agnes A. Mooslechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study 2025 ·Transplant International ·(unknown), (unknown), Agnes A. Mooslechner, (unknown), Barbara Prietl, (unknown), Alexander H. Kirsch, Alexander R. Rosenkranz, Katharina Artinger, Kathrin Eller	1
2	Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis 2025 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), Agnes A. Mooslechner, (unknown), (unknown), (unknown), (unknown), Wolfgang Platzer, Clemens Aigner, Alberto Benazzo, Stefano Angiari, Leigh M. Marsh, Grażyna Kwapiszewska, Ákos Heinemann, Thomas Bärnthaler	2
3	Deficiency of the Synaptic Adhesion Protein Leucine‐Rich Repeat Transmembrane Protein 4 Like 1 Affects Anxiety and Aggression in Zebrafish 2025 ·Acta Physiologica ·(unknown), (unknown), (unknown), (unknown), Agnes A. Mooslechner, Thomas Bärnthaler, Giovanny Rodriguez Blanco, Florian Reichmann	1
4	Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients 2024 ·Transplant International ·Agnes A. Mooslechner, (unknown), (unknown), (unknown), Barbara Prietl, Alexander H. Kirsch, Philipp Stiegler, Robert Sucher, Harald Sourij, Alexander R. Rosenkranz, Kathrin Eller	2
5	Young EFIS: Three years of progress – Reflecting on achievements and embracing new horizons 2023 ·European Journal of Immunology ·(unknown), Anne M. Hahn, Annika Hausmann, (unknown), Gizem Kılıç, (unknown), Agnes A. Mooslechner, Noushin Mossadegh‐Keller, (unknown), Rami Bechara, (unknown)	1
6	B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response 2022 ·Frontiers in Medicine ·(unknown), (unknown), Alexander H. Kirsch, (unknown), Agnes A. Mooslechner, Alexander R. Rosenkranz, Philipp Stiegler, Peter Schemmer, Harald Sourij, Philipp Eller, Barbara Prietl, Kathrin Eller	8
7	Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8+ T Cells 2022 ·Cells ·Agnes A. Mooslechner, (unknown), Katharina Artinger, Alexander H. Kirsch, (unknown), Philipp Eller, Alexander R. Rosenkranz, Kathrin Eller	2
8	Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis 2021 ·Kidney International ·Katharina Artinger, Alexander H. Kirsch, Agnes A. Mooslechner, Daniel J Cooper, (unknown), (unknown), (unknown), (unknown), (unknown), Philipp Eller, Hideo Yagita∥, Anna Lena Illert, Alexander R. Rosenkranz, Peter J. L. Lane, Kathrin Eller	5
9	Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice 2021 ·Journal of Clinical Medicine ·(unknown), Katharina Artinger, (unknown), Thomas Bärnthaler, Agnes A. Mooslechner, Andrijana Kirsch, Marion J. Pollheimer, Philipp Eller, Alexander R. Rosenkranz, Ákos Heinemann, Kathrin Eller	3
10	Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation 2019 ·American Journal Of Pathology ·(unknown), Alexander H. Kirsch, (unknown), (unknown), Katharina Artinger, (unknown), (unknown), Agnes A. Mooslechner, (unknown), Marion J. Pollheimer, Tobias Niedrist, Andreas Meinitzer, Daniel J. Drucker, Thomas R. Pieber, Philipp Eller, Alexander R. Rosenkranz, Ákos Heinemann, Kathrin Eller	49
11	Blockade of prostaglandin E₂ receptor 4 ameliorates nephrotoxic serum nephritis 2018 ·American Journal of Physiology-Renal Physiology ·(unknown), Katharina Artinger, Alexander H. Kirsch, (unknown), Katharina Jandl, Thomas Bärnthaler, Agnes A. Mooslechner, Sereina A. Herzog, (unknown), Andrijana Kirsch, Saša Frank, (unknown), Marion J. Pollheimer, Philipp Eller, Alexander R. Rosenkranz, Ákos Heinemann, Kathrin Eller	11
12	Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome 2015 ·Human Immunology ·(unknown), Madlen Loebel, Agnes A. Mooslechner, Michael Knops, Leif G. Hanitsch, Patricia Grabowski, Kirsten Wittke, Christian Meisel, Nadine Unterwalder, Hans‐Dieter Volk, Carmen Scheibenbogen	25
13	Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome 2015 ·Journal of Translational Medicine ·Madlen Löbel, Agnes A. Mooslechner, Sandra Bauer, (unknown), Anne Letsch, Leif G. Hanitsch, Patricia Grabowski, Christian Meisel, Hans‐Dieter Volk, Carmen Scheibenbogen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact